FOXO3a elicits a pro-apoptotic transcription program and cellular response to human lung carcinogen nicotine-derived nitrosaminoketone (NNK)

被引:22
作者
Blake, Daniel C., Jr. [1 ]
Mikse, Oliver R. [1 ]
Freeman, Willard M. [1 ]
Herzog, Christopher R. [1 ]
机构
[1] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA
关键词
FOXO3a; Lung adenocarcinoma; NNK; Apoptosis; Expression microarray; DNA-REPAIR; KAPPA-B; CANCER; KINASE; DIFFERENTIATION; CHECKPOINT; PATHWAYS; SURVIVAL; STRESS; P53;
D O I
10.1016/j.lungcan.2009.03.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Long-term carcinogen exposure exerts continuous pressure on key mechanisms that repair or eliminate carcinogen-damaged cells giving rise to selective failures that contribute to lung cancer. FOXO3a is a transcription factor that elicits a protective response to diverse cellular stresses. Although implicated as a tumor suppressor, its role in sporadic cancer is uncertain. We recently observed that FOXO3a gene inactivation occurs frequently in carcinogen-induced lung adenocarcinoma (LAC). This suggests that FOXO3a may play a role in LAC suppression by eliciting a protective response to carcinogenic stress. Here we investigated this possibility by examining the role of FOXO3a in the cellular response to nicotine-derived nitrosaminoketone (NNK), a lung carcinogen implicated as a cause of human LAC. We show that restoration of FOXO3a in FOXO3a-deficient LAC cells increases sensitivity to apoptosis caused by a DNA-damaging intermediate of NNK Prior to this cellular outcome, FOXO3a is functionally activated and mediates a large-scale transcription program in response to this damage involving a significant modulation of 440 genes. Genes most significantly represented in this program are those with roles in cell growth and proliferation > protein synthesis > gene expression > cell death > cell cycle. The results of this study show that FOXO3a directs an anti-carcinogenic transcription program that culminates in the elimination of carcinogen-damaged cells. This suggests that FOXO3a is a potential suppressor of carcinogenic damage in LAC. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:37 / 47
页数:11
相关论文
共 42 条
[1]
[Anonymous], 2008, CANC FACTS FIG 2007
[2]
[Anonymous], 2002, MON EV CARC RISKS HU
[3]
FOXO3a is activated in response to hypoxic stress and inhibits HiF1-induced apoptosis via regulation of CITED2 [J].
Bakker, Walbert J. ;
Harris, Isaac S. ;
Mak, Tak W. .
MOLECULAR CELL, 2007, 28 (06) :941-953
[4]
Carcinogen-specific induction of genetic instability [J].
Bardelli, A ;
Cahill, CP ;
Lederer, G ;
Speicher, MR ;
Kinzler, KW ;
Vogelstein, B ;
Lengauer, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) :5770-5775
[5]
DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis [J].
Bernstein, C ;
Bernstein, H ;
Payne, CM ;
Garewal, H .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2002, 511 (02) :145-178
[6]
Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis [J].
Breivik, J ;
Gaudernack, G .
SEMINARS IN CANCER BIOLOGY, 1999, 9 (04) :245-254
[7]
Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor [J].
Brunet, A ;
Bonni, A ;
Zigmond, MJ ;
Lin, MZ ;
Juo, P ;
Hu, LS ;
Anderson, MJ ;
Arden, KC ;
Blenis, J ;
Greenberg, ME .
CELL, 1999, 96 (06) :857-868
[8]
Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a [J].
Castrillon, DH ;
Miao, LL ;
Kollipara, R ;
Horner, JW ;
DePinho, RA .
SCIENCE, 2003, 301 (5630) :215-218
[9]
PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a) [J].
Emerling, Brooke M. ;
Weinberg, Frank ;
Liu, Juinn-Lin ;
Mak, Tak W. ;
Chandel, Navdeep S. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (07) :2622-2627
[10]
FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells [J].
Fernandez de Mattos, Silvia ;
Villalonga, Priam ;
Clardy, Jon ;
Lam, Eric W-F. .
MOLECULAR CANCER THERAPEUTICS, 2008, 7 (10) :3237-3246